A novel anti-thrombotic heparinoid (ORG 10172) devoid of bleeding inducing capacity: A survey of its pharmacological properties in experimental animal models
Authors:
- D.G. MeulemanDMD.G. Meuleman
- P.M.J. HobbelenPHP.M.J. Hobbelen
- G. van DedemGDG. van Dedem
- H.C.T. MoelkerHMH.C.T. Moelker
- 1 August 1982
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 27 (3) , 353-363
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of intra-arterial cannulation on blood platelet consumption in ratsThrombosis Research, 1980
- Predictors of bleeding during heparin therapyJAMA, 1980
- Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombinThrombosis Research, 1980
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238)Thrombosis Research, 1978
- HÆMORRHAGIC COMPLICATIONS OF HEPARIN THERAPYThe Lancet, 1977
- Prevention of Venous ThromboembolismSeminars in Thrombosis and Hemostasis, 1976
- Management of Heparin TherapyNew England Journal of Medicine, 1975
- Small Subcutaneous Doses of Heparin in Prevention of Venous ThrombosisNew England Journal of Medicine, 1973
- The Partial Thromboplastin Time with Kaolin: A Simple Screening Test for First Stage Plasma Clotting Factor DeficienciesAmerican Journal of Clinical Pathology, 1961